Status:
RECRUITING
The Effects of the Female Hormones on Cerebral Perfusion
Lead Sponsor:
University Ghent
Conditions:
Cerebral Perfusion
Contraception
Eligibility:
FEMALE
18-25 years
Brief Summary
Measuring brain perfusion is biased by a inter- and intrasubject variability, caused by physiological and lifestyle factors. In this study, the investigators want to investigate the variations in cere...
Eligibility Criteria
Inclusion
- Bachelor or Master student
- Minimum of 3 months not using contraception of using Deso20
Exclusion
- No informed consent
- MRI-contraindications
- Claustrophobia
- Pregnancy or breastfeeding
- Chronic diseases and chronic medication use
- Smoker
- Drug use
- Abuse of alcohol and caffeine
Key Trial Info
Start Date :
October 3 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT03299179
Start Date
October 3 2016
End Date
December 31 2027
Last Update
December 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ghent University Hospital
Ghent, Belgium, 9000